GR3018322T3 - Leukotriene b 4 antagonists. - Google Patents
Leukotriene b 4 antagonists.Info
- Publication number
- GR3018322T3 GR3018322T3 GR950403300T GR950403300T GR3018322T3 GR 3018322 T3 GR3018322 T3 GR 3018322T3 GR 950403300 T GR950403300 T GR 950403300T GR 950403300 T GR950403300 T GR 950403300T GR 3018322 T3 GR3018322 T3 GR 3018322T3
- Authority
- GR
- Greece
- Prior art keywords
- alkyl
- leukotriene
- antagonists
- compounds
- formula
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- VNYSSYRCGWBHLG-AMOLWHMGSA-M leukotriene B4(1-) Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC([O-])=O VNYSSYRCGWBHLG-AMOLWHMGSA-M 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Spray-Type Burners (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/545,430 US5124350A (en) | 1990-06-28 | 1990-06-28 | Leukotriene b4 antagonists |
| PCT/US1991/004386 WO1992000011A2 (en) | 1990-06-28 | 1991-06-27 | Leukotriene b4 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3018322T3 true GR3018322T3 (en) | 1996-03-31 |
Family
ID=24176217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR950403300T GR3018322T3 (en) | 1990-06-28 | 1995-12-07 | Leukotriene b 4 antagonists. |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US5124350A (da) |
| EP (1) | EP0593478B1 (da) |
| JP (1) | JP2942630B2 (da) |
| AT (1) | ATE131165T1 (da) |
| AU (1) | AU8528291A (da) |
| CA (1) | CA2081766C (da) |
| DE (1) | DE69115297T2 (da) |
| DK (1) | DK0593478T3 (da) |
| ES (1) | ES2080334T3 (da) |
| GR (1) | GR3018322T3 (da) |
| IE (1) | IE62680B1 (da) |
| PT (1) | PT98140B (da) |
| WO (1) | WO1992000011A2 (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5124350A (en) * | 1990-06-28 | 1992-06-23 | G. D. Searle & Co. | Leukotriene b4 antagonists |
| US5488160A (en) * | 1991-06-11 | 1996-01-30 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and method of treatment |
| US5451700A (en) * | 1991-06-11 | 1995-09-19 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and methods of treatment |
| US5273999A (en) * | 1991-09-10 | 1993-12-28 | Hoffmann-La Roche Inc. | Carboxylic acid leukotriene B4 antagonists |
| US5252599A (en) * | 1992-08-27 | 1993-10-12 | Merck Frosst Canada, Inc. | Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis |
| US5455274A (en) * | 1992-12-09 | 1995-10-03 | Ciba-Geigy Corporation | Hydroxyamidine derivatives |
| US5324743A (en) * | 1992-12-10 | 1994-06-28 | Eli Lilly And Company | Leukotriene B4 antagonists |
| US5516917A (en) * | 1994-06-08 | 1996-05-14 | G. D. Searle & Co. | Leukotriene B4 antagonists |
| KR100232340B1 (ko) * | 1994-10-13 | 1999-12-01 | 디. 제이. 우드, 스피겔 알렌 제이 | 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물 |
| EP0785930A1 (en) * | 1994-10-13 | 1997-07-30 | Pfizer Inc. | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b 4? (ltb 4?) antagonists |
| AU6269496A (en) | 1995-06-12 | 1997-01-09 | G.D. Searle & Co. | Combination of a cyclooxygenase-2 inhibitor and a leukotrien e b4 receptor antagonist for the treatment of infla mmations |
| EP1640003A2 (en) | 1996-02-13 | 2006-03-29 | G.D. SEARLE & CO. | Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist |
| US6403684B1 (en) * | 1998-12-16 | 2002-06-11 | General Electric Company | Polyetherimide resin/polyester resin blends having improved visual clarity |
| AU2001292874B2 (en) | 2000-09-27 | 2006-06-15 | Merck & Co., Inc. | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| EP1347755A2 (en) | 2000-10-31 | 2003-10-01 | Merck & Co., Inc. | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| RU2007101510A (ru) * | 2004-07-22 | 2008-08-27 | Фармаци Корпорейшн (US) | Композиции для лечения воспаления и боли с использованием комбинации селективного ингибитора сох-2 и антагониста рецептора ltb4 |
| US7572600B2 (en) * | 2004-08-04 | 2009-08-11 | Chemocentryx, Inc. | Enzymatic activities in chemokine-mediated inflammation |
| CA2604042C (en) | 2005-04-13 | 2016-06-21 | Astex Therapeutics Limited | Pharmaceutical compounds |
| US7754725B2 (en) * | 2006-03-01 | 2010-07-13 | Astex Therapeutics Ltd. | Dihydroxyphenyl isoindolymethanones |
| WO2008044029A1 (en) * | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
| US8916552B2 (en) * | 2006-10-12 | 2014-12-23 | Astex Therapeutics Limited | Pharmaceutical combinations |
| JP5528807B2 (ja) * | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | 複合薬剤 |
| GB0620259D0 (en) * | 2006-10-12 | 2006-11-22 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| WO2008044027A2 (en) * | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
| EP2073804B1 (en) | 2006-10-12 | 2017-09-13 | Astex Therapeutics Limited | Hydroxy-substituted benzoic acid amide compounds for use in the treatment of pain |
| GB0806527D0 (en) * | 2008-04-11 | 2008-05-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| US10500178B2 (en) | 2015-03-13 | 2019-12-10 | The Board Of Trustees Of The Leland Stanford Junior University | LTB4 inhibition to prevent and treat human lymphedema |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1384530A (en) * | 1971-07-29 | 1975-02-19 | Fisons Ltd | Chromone derivatives |
| ATE14579T1 (de) * | 1979-03-20 | 1985-08-15 | Fisons Plc | Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen. |
| FI802783A7 (fi) * | 1979-09-05 | 1981-01-01 | Glaxo Group Ltd | Fenolijohdoksia. |
| US4474788A (en) * | 1981-11-12 | 1984-10-02 | Fisons Plc | Anti-SRSA quinoline carboxylic acid derivatives |
| ZA844519B (en) * | 1983-06-24 | 1985-02-27 | Hoffmann La Roche | Dihydrobenzopyran derivatives |
| US4778903A (en) * | 1983-12-12 | 1988-10-18 | G. D. Searle & Co. | Substituted dihydrobenzopyrans |
| US4665203A (en) * | 1983-08-08 | 1987-05-12 | G. D. Searle & Co. | Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors |
| US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
| US4546194A (en) * | 1984-05-29 | 1985-10-08 | G. D. Searle & Co. | Substituted chromanon-2-yl alkanols and derivatives thereof |
| US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
| EP0336068A1 (en) * | 1988-02-11 | 1989-10-11 | F. Hoffmann-La Roche Ag | Phenoxyalkoxy-3,4-dihydro-2H-1-benzopyran derivatives |
| US5124350A (en) * | 1990-06-28 | 1992-06-23 | G. D. Searle & Co. | Leukotriene b4 antagonists |
| DE4206523A1 (de) * | 1992-03-02 | 1993-09-09 | Vdo Schindling | Vorrichtung zur verstellung einer drosselklappe |
-
1990
- 1990-06-28 US US07/545,430 patent/US5124350A/en not_active Expired - Lifetime
-
1991
- 1991-06-27 DE DE69115297T patent/DE69115297T2/de not_active Expired - Fee Related
- 1991-06-27 WO PCT/US1991/004386 patent/WO1992000011A2/en not_active Ceased
- 1991-06-27 JP JP3515594A patent/JP2942630B2/ja not_active Expired - Fee Related
- 1991-06-27 CA CA002081766A patent/CA2081766C/en not_active Expired - Fee Related
- 1991-06-27 AU AU85282/91A patent/AU8528291A/en not_active Abandoned
- 1991-06-27 IE IE225591A patent/IE62680B1/en not_active IP Right Cessation
- 1991-06-27 AT AT91916271T patent/ATE131165T1/de not_active IP Right Cessation
- 1991-06-27 DK DK91916271.9T patent/DK0593478T3/da active
- 1991-06-27 ES ES91916271T patent/ES2080334T3/es not_active Expired - Lifetime
- 1991-06-27 EP EP91916271A patent/EP0593478B1/en not_active Expired - Lifetime
- 1991-06-28 PT PT98140A patent/PT98140B/pt not_active IP Right Cessation
-
1992
- 1992-12-23 US US07/995,859 patent/US5310951A/en not_active Expired - Lifetime
-
1994
- 1994-03-03 US US08/205,909 patent/US5439937A/en not_active Expired - Fee Related
-
1995
- 1995-05-19 US US08/445,059 patent/US5532383A/en not_active Expired - Fee Related
- 1995-12-07 GR GR950403300T patent/GR3018322T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT98140B (pt) | 1998-12-31 |
| ATE131165T1 (de) | 1995-12-15 |
| WO1992000011A3 (en) | 1992-02-06 |
| WO1992000011A2 (en) | 1992-01-09 |
| US5439937A (en) | 1995-08-08 |
| IE62680B1 (en) | 1995-02-22 |
| US5124350A (en) | 1992-06-23 |
| ES2080334T3 (es) | 1996-02-01 |
| AU8528291A (en) | 1992-01-23 |
| CA2081766A1 (en) | 1991-12-29 |
| PT98140A (pt) | 1993-09-30 |
| EP0593478A1 (en) | 1994-04-27 |
| CA2081766C (en) | 2002-10-08 |
| US5310951A (en) | 1994-05-10 |
| IE912255A1 (en) | 1992-01-01 |
| DE69115297T2 (de) | 1996-06-13 |
| JPH05507720A (ja) | 1993-11-04 |
| JP2942630B2 (ja) | 1999-08-30 |
| DE69115297D1 (de) | 1996-01-18 |
| EP0593478B1 (en) | 1995-12-06 |
| DK0593478T3 (da) | 1996-01-08 |
| US5532383A (en) | 1996-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3018322T3 (en) | Leukotriene b 4 antagonists. | |
| GR3015349T3 (en) | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof. | |
| SE8201854L (sv) | N-substituerade amino-aminosyror | |
| DE3483165D1 (de) | Cephalosporinderivate. | |
| ES8503667A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina. | |
| ZM987A1 (en) | New dihydrobenzofuran and chroman-carboxamide derivatives,processes for the preparation thereof and use thereof as neuroleptics | |
| ES8705852A1 (es) | Un procedimiento para la preparacion de nuevas benzamidas sustituidas | |
| CA2449679A1 (en) | Androstenones | |
| GR3007401T3 (da) | ||
| ES2055235T3 (es) | Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation. | |
| ES482285A1 (es) | Procedimiento de preparacion de compuestos de benzofurano. | |
| ES8504103A1 (es) | Un procedimiento para preparar derivados de ciclobutano | |
| ES2062792T3 (es) | Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos. | |
| GB8921792D0 (en) | New compositions of matter | |
| TW225989B (da) | ||
| TW334428B (en) | Novel benzodiazepine derivatives | |
| DE69001004D1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| ES488387A1 (es) | Procedimiento de preparacion de derivados condensados de pi-rrolidina | |
| TNSN86099A1 (fr) | Nouveaux benzamides, leur procede de preparation et leur application dans le domaine therapeutique | |
| GR3035010T3 (en) | New derivatives of glycylanilides, preparation and therapeutical application |